A detailed history of Fmr LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,094,974 shares of GLUE stock, worth $31.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,094,974
Previous 5,340,802 4.6%
Holding current value
$31.8 Million
Previous $37.7 Million 49.39%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$3.38 - $7.86 $830,898 - $1.93 Million
-245,828 Reduced 4.6%
5,094,974 $19.1 Million
Q1 2024

May 13, 2024

SELL
$4.26 - $8.46 $836,821 - $1.66 Million
-196,437 Reduced 3.55%
5,340,802 $37.7 Million
Q4 2023

Feb 13, 2024

SELL
$2.5 - $5.93 $1.17 Million - $2.77 Million
-467,594 Reduced 7.79%
5,537,239 $31.3 Million
Q3 2023

Nov 13, 2023

SELL
$4.78 - $7.22 $2.59 Million - $3.91 Million
-540,899 Reduced 8.26%
6,004,833 $28.8 Million
Q2 2023

Aug 11, 2023

BUY
$4.53 - $8.4 $564,859 - $1.05 Million
124,693 Added 1.94%
6,545,732 $44.8 Million
Q1 2023

May 11, 2023

BUY
$5.95 - $8.21 $1.21 Million - $1.67 Million
203,581 Added 3.27%
6,421,039 $50 Million
Q4 2022

Feb 13, 2023

BUY
$6.71 - $9.72 $83,767 - $121,344
12,484 Added 0.2%
6,217,458 $47.3 Million
Q3 2022

Nov 10, 2022

SELL
$7.17 - $12.16 $54,276 - $92,051
-7,570 Reduced 0.12%
6,204,974 $50.7 Million
Q2 2022

Aug 12, 2022

SELL
$6.15 - $14.99 $4.81 Million - $11.7 Million
-782,004 Reduced 11.18%
6,212,544 $60.1 Million
Q1 2022

May 13, 2022

BUY
$10.36 - $20.41 $193,327 - $380,871
18,661 Added 0.27%
6,994,548 $98.1 Million
Q4 2021

Feb 14, 2022

BUY
$16.28 - $27.15 $302,856 - $505,071
18,603 Added 0.27%
6,975,887 $142 Million
Q3 2021

Nov 15, 2021

BUY
$18.59 - $42.21 $49.2 Million - $112 Million
2,645,025 Added 61.34%
6,957,284 $155 Million
Q2 2021

Aug 13, 2021

BUY
$18.86 - $22.7 $81.3 Million - $97.9 Million
4,312,259 New
4,312,259 $97.9 Million

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $292M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.